Thomas W. LeBlanc, MD, MA, discusses how erythroid maturation agents (EMAs), such as luspatercept, are increasingly important in the anemia management landscape for low-risk myelodysplastic syndromes ...
Dr. Helen M. Ranney revolutionized the understanding of sickle cell anemia through her groundbreaking research, paving the way for advancements in treatment and diagnosis. Her achievements extended ...